blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4367217

EP4367217 - RECOMBINANT MICROORGANISM-BASED METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  12.04.2024
Database last updated on 03.10.2024
FormerThe international publication has been made
Status updated on  13.01.2023
Most recent event   Tooltip13.09.2024Change: Validation statespublished on 16.10.2024 [2024/42]
13.09.2024Change - extension statespublished on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Baylor College of Medicine
One Baylor Plaza
Houston, TX 77030 / US
[2024/20]
Inventor(s)01 / BRITTON, Robert
Houston, Texas 77030 / US
02 / BEETON, Christine
Houston, Texas 77030 / US
03 / HYSER, Joseph
Houston, Texas 77030 / US
 [2024/20]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2024/20]
Application number, filing date22838609.008.07.2022
[2024/20]
WO2022US73569
Priority number, dateUS202163219717P08.07.2021         Original published format: US 202163219717 P
[2024/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2023283646
Date:12.01.2023
Language:EN
[2023/02]
Type: A1 Application with search report 
No.:EP4367217
Date:15.05.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 12.01.2023 takes the place of the publication of the European patent application.
[2024/20]
Search report(s)International search report - published on:US12.01.2023
ClassificationIPC:C12N1/20, A61K35/741, A61K38/02
[2024/20]
CPC:
C12N1/20 (EP); A61K35/741 (EP); C07K14/43504 (EP);
C07K2319/02 (EP); C12R2001/225 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/20]
TitleGerman:AUF REKOMBINANTEN MIKROORGANISMEN BASIERENDE VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON KRANKHEITEN[2024/20]
English:RECOMBINANT MICROORGANISM-BASED METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASE[2024/20]
French:MÉTHODES ET COMPOSITIONS À BASE DE MICRO-ORGANISMES RECOMBINÉS POUR LE TRAITEMENT D'UNE MALADIE[2024/20]
Entry into regional phase11.01.2024National basic fee paid 
11.01.2024Search fee paid 
11.01.2024Designation fee(s) paid 
11.01.2024Examination fee paid 
Examination procedure11.01.2024Examination requested  [2024/20]
09.08.2024Amendment by applicant (claims and/or description)
Fees paidPenalty fee
Additional fee for renewal fee
31.07.202403   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO0003687  (ELAN PHARM INC [US]) [A] 1-3 * entire document *;
 [A]US2003059923  (FEDER JOHN N [US], et al) [A] 1-3* entire document *;
 [A]US2006183105  (AIYAR JAYASHREE [US], et al) [A] 1-3 * entire document *;
 [X]US2020262877  (MEHLIN CHRISTOPHER [US], et al) [X] 1-3 * entire document *;
 [A]  - Anangi Raveendra, Koshy Shyny, Huq Redwan, Beeton Christine, Chuang Woei-Jer, King Glenn F., "Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of KV1.3 Channel Blockers", PLoS ONE, (20121201), vol. 7, no. 12, doi:10.1371/journal.pone.0052965, page e52965, XP093023432 [A] 1-3 * . entire document *

DOI:   http://dx.doi.org/10.1371/journal.pone.0052965
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.